|
ATE482747T1
(de)
*
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
Neue amide derivate und deren pharmazeutische verwendungen
|
|
CN100582089C
(zh)
|
2003-11-21 |
2010-01-20 |
吉万奥丹股份有限公司 |
N-取代的对-薄荷烷甲酰胺
|
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
US8415354B2
(en)
|
2004-04-29 |
2013-04-09 |
Abbott Laboratories |
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
US20100222316A1
(en)
|
2004-04-29 |
2010-09-02 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
AU2005240784C1
(en)
|
2004-05-07 |
2011-12-22 |
Janssen Pharmaceutica N.V. |
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
GB0418877D0
(en)
*
|
2004-08-24 |
2004-09-29 |
Univ Edinburgh |
Heart
|
|
DE602005017159D1
(de)
|
2004-08-30 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Oxysteroid-dehydrogenase-inhibitoren
|
|
CN101300005B
(zh)
*
|
2004-08-30 |
2013-05-01 |
詹森药业有限公司 |
作为11-β羟类固醇脱氢酶抑制剂的N-2金刚烷基-2-苯氧基-乙酰胺衍生物
|
|
CA2576850C
(en)
|
2004-08-30 |
2013-06-25 |
Janssen Pharmaceutica N.V. |
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
BRPI0515500A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados piridazina para inibição de estearoil-coa-desaturase
|
|
AU2005286728A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
MX2007003332A
(es)
|
2004-09-20 |
2007-06-05 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
|
|
CN101084211A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其作为治疗剂的用途
|
|
MX2007003318A
(es)
*
|
2004-09-20 |
2007-05-18 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como agentes terapeuticos.
|
|
BRPI0515482A
(pt)
|
2004-09-20 |
2008-07-22 |
Xenon Pharmaceuticals Inc |
derivados heterocìclicos e seus usos como agentes terapêuticos
|
|
EP1807080A1
(en)
*
|
2004-10-29 |
2007-07-18 |
AstraZeneca AB |
Use of unsaturated quionoline or naphtalene derivatives as medicaments
|
|
US20090093463A1
(en)
*
|
2004-11-02 |
2009-04-09 |
Agouron Pharmaceuticals Inc. |
Novel compounds of substituted and unsubtituted adamantyl amides
|
|
EP1817295B1
(en)
|
2004-11-18 |
2012-11-07 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
US20090192198A1
(en)
|
2005-01-05 |
2009-07-30 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
MX2007008238A
(es)
|
2005-01-05 |
2007-08-17 |
Abbott Lab |
Derivados de adamantilo como inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo 1.
|
|
CN101142172A
(zh)
|
2005-01-05 |
2008-03-12 |
艾博特公司 |
11-β-羟甾类脱氢酶1型酶的抑制剂
|
|
US8198331B2
(en)
|
2005-01-05 |
2012-06-12 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
FR2880887B1
(fr)
*
|
2005-01-14 |
2009-01-30 |
Merck Sante Soc Par Actions Si |
Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
|
|
EP1866285A1
(en)
*
|
2005-03-03 |
2007-12-19 |
F. Hoffmann-Roche AG |
1-sulfonyl-piperdine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus
|
|
US20080153791A1
(en)
*
|
2005-03-18 |
2008-06-26 |
Onpharm Gmbh |
11Beta -Hydroxysteroid Dehydrogenases
|
|
GB0506133D0
(en)
*
|
2005-03-24 |
2005-05-04 |
Sterix Ltd |
Compound
|
|
EP1928840B1
(en)
|
2005-04-05 |
2011-08-10 |
F. Hoffmann-La Roche AG |
1H-Pyrazole-4-carboxamides, their preparation and their use as 11-beta-hydroxysteroid dehydrogenase inhibitors
|
|
CA2618646A1
(en)
|
2005-06-03 |
2007-11-15 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
|
JP5118039B2
(ja)
|
2005-08-18 |
2013-01-16 |
シンタ ファーマシューティカルズ コーポレーション |
Ｈｓｐ９０活性を調節するトリアゾール化合物
|
|
US7622492B2
(en)
|
2005-08-31 |
2009-11-24 |
Hoffmann-La Roche Inc. |
Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
|
|
GB2429975A
(en)
*
|
2005-09-08 |
2007-03-14 |
Univ Edinburgh |
1,5-substituted-1H-tetrazole 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
JP5052518B2
(ja)
|
2005-10-06 |
2012-10-17 |
シェーリング コーポレイション |
プロテインキナーゼインヒビターとしてのピラゾロピリミジン
|
|
BRPI0710479A2
(pt)
|
2006-01-18 |
2012-08-14 |
Hoffmann La Roche |
composto, processo para sua preparaÇço, composiÇço farmacÊutica, uso de um composto e mÉtodo de tratamento de doenÇa ou desosrdem metabàlica.
|
|
WO2007092435A2
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
11-beta hsd1 inhibitors
|
|
HUE026011T2
(en)
|
2006-03-22 |
2016-05-30 |
Hoffmann La Roche |
Pyrazoles as 11-beta-HSD-1
|
|
US7524848B2
(en)
|
2006-03-23 |
2009-04-28 |
Amgen Inc. |
Diaza heterocyclic amide compounds and their uses
|
|
EP2038262B1
(en)
|
2006-05-25 |
2014-11-12 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
MX2009001036A
(es)
|
2006-08-04 |
2009-04-23 |
Merz Pharma Gmbh & Co Kgaa |
Pirazolopirimidinas, proceso para su preparacion y su uso como medicina.
|
|
MX2009002019A
(es)
|
2006-08-24 |
2009-03-09 |
Novartis Ag |
Derivados de 2-(pirazin-2-il)-tiazol y 2-(1h-pirazol-3-il)-tiazol asi como compuestos relacionados como inhibidores de la estearoil-coa-desaturasa (scd) para el tratamiento de trastornos metabolicos, cardiovasculares, y otros.
|
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
CA2662574A1
(en)
|
2006-09-22 |
2008-03-27 |
Novartis Ag |
Heterocyclic organic compounds
|
|
AU2007340273B2
(en)
|
2006-10-17 |
2012-08-30 |
Rutgers, The State University Of New Jersey |
N-substituted monomers and polymers
|
|
KR20080052024A
(ko)
*
|
2006-12-07 |
2008-06-11 |
(주)아모레퍼시픽 |
아세틸-조효소 ａ 카복실라제 저해활성을 갖는트리아졸로피리다진 유도체
|
|
WO2008074835A1
(en)
|
2006-12-20 |
2008-06-26 |
Novartis Ag |
2-substituted 5-membered heterocycles as scd inhibitors
|
|
EP1935420A1
(en)
*
|
2006-12-21 |
2008-06-25 |
Merck Sante |
2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
|
|
EP2119719A1
(en)
*
|
2006-12-26 |
2009-11-18 |
Daiichi Sankyo Company, Limited |
Thiazepine derivative
|
|
EP2150526B1
(en)
|
2007-02-23 |
2017-09-20 |
vTv Therapeutics LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
WO2008101885A1
(en)
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2125704A1
(en)
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
WO2008134035A1
(en)
*
|
2007-04-27 |
2008-11-06 |
Panacos Pharmaceuticals, Inc. |
Alpha-unsubstituted arylmethyl piperazine pyrazolo[1,5-a] pyrimidine amide derivatives
|
|
KR101530019B1
(ko)
*
|
2007-06-07 |
2015-06-18 |
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. |
혈관성형술 또는 동맥내막절제술 후 재협착 및 장기 섬유증으로 인한 질환의 치료에 유용한 5베타, 14베타-안드로스테인 유도체
|
|
ES2423181T3
(es)
|
2007-07-17 |
2013-09-18 |
F. Hoffmann-La Roche Ag |
Inhibidores de la 11ß-hidroxiesteroide-deshidrogenasa
|
|
US8263591B2
(en)
|
2007-08-10 |
2012-09-11 |
Cortex Pharmaceuticals, Inc. |
Bicyclic amides for enhancing glutamatergic synaptic responses
|
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
JP5606925B2
(ja)
*
|
2008-01-25 |
2014-10-15 |
ロディア オペレーションズ |
エステルアミドの溶剤としての使用、新規のエステルアミド及びエステルアミドの製造方法
|
|
CN102202669A
(zh)
*
|
2008-10-28 |
2011-09-28 |
利兰·斯坦福青年大学托管委员会 |
醛脱氢酶调节剂及其使用方法
|
|
WO2010096115A1
(en)
|
2008-10-29 |
2010-08-26 |
Apath, Llc |
Compounds, compositions and methods for control of hepatitis c viral infections
|
|
US8927549B2
(en)
|
2008-11-21 |
2015-01-06 |
High Point Pharmaceuticals, Llc |
Adamantyl benzamide derivatives
|
|
EP2243494A1
(en)
*
|
2009-04-22 |
2010-10-27 |
OntoChem GmbH |
Pharmaceutical composition, comprising a steroid-dehydrogenase-reductase inhibitor, and a mineralocorticoid receptor antagonist.
|
|
KR101774035B1
(ko)
|
2009-10-30 |
2017-09-01 |
얀센 파마슈티카 엔.브이. |
이미다조［１，２―ｂ］피리다진 유도체 및 ＰＤＥ１０ 저해제로서의 그의 용도
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
EP2560640A1
(en)
|
2010-04-19 |
2013-02-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
|
|
WO2012015715A1
(en)
|
2010-07-27 |
2012-02-02 |
High Point Pharmaceuticals, Llc |
Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
|
|
CN105394046B
(zh)
|
2010-10-25 |
2019-03-01 |
范德比尔特大学 |
用于抑制昆虫宿主感觉的组合物
|
|
GB201103103D0
(en)
|
2011-02-23 |
2011-04-06 |
Givaudan Sa |
Organic compounds
|
|
US9578881B2
(en)
*
|
2011-05-06 |
2017-02-28 |
Vanderbilt University |
Compositions for inhibition of insect sensing
|
|
WO2013000924A1
(en)
|
2011-06-27 |
2013-01-03 |
Janssen Pharmaceutica Nv |
1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
|
|
JP2014534228A
(ja)
|
2011-11-02 |
2014-12-18 |
シンタ ファーマシューティカルズ コーポレーション |
白金含有剤とｈｓｐ９０阻害剤の組合せ療法
|
|
CA2853799A1
(en)
|
2011-11-02 |
2013-05-10 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
|
|
US9402831B2
(en)
|
2011-11-14 |
2016-08-02 |
Synta Pharmaceutical Corp. |
Combination therapy of HSP90 inhibitors with BRAF inhibitors
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
ITMI20120786A1
(it)
*
|
2012-05-09 |
2013-11-10 |
Fond Italiana Sclerosi M Ultipla Fism Onlu |
Modulatori del recettore gpr17
|
|
WO2014001314A1
(en)
|
2012-06-26 |
2014-01-03 |
Janssen Pharmaceutica Nv |
Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
|
AU2013289284B2
(en)
|
2012-07-09 |
2017-03-30 |
Janssen Pharmaceutica Nv |
Inhibitors of phosphodiesterase 10 enzyme
|
|
US10092574B2
(en)
|
2012-09-26 |
2018-10-09 |
Valorisation-Recherche, Limited Partnership |
Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
|
|
CA2902333C
(en)
|
2013-03-13 |
2021-06-08 |
Unilever Plc |
Cosmetic compositions with tricyclodecane amides
|
|
MX352873B
(es)
|
2013-03-13 |
2017-12-13 |
Unilever Nv |
Composiciones fotoprotectoras con triciclodecano amidas.
|
|
CA2902494C
(en)
|
2013-03-13 |
2021-01-26 |
Unilever Plc |
Prolonged delivery of certain fragrance components from personal care compositions
|
|
WO2014152018A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
|
US9938291B2
(en)
|
2013-03-14 |
2018-04-10 |
The Trustess Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
|
WO2014160185A2
(en)
|
2013-03-14 |
2014-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
|
EP3495357B1
(en)
*
|
2013-03-14 |
2021-05-05 |
The Trustees of Columbia University in the City of New York |
4-phenylpiperidines, their preparation and use
|
|
EP2968266B1
(en)
*
|
2013-03-15 |
2019-05-01 |
Shifa Biomedical Corporation |
Anti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) compounds in the treatment and/or prevention of cardiovascular diseases
|
|
EP2970177A1
(en)
|
2013-03-15 |
2016-01-20 |
Pfizer Inc. |
Indole compounds that activate ampk
|
|
CN103420931B
(zh)
*
|
2013-05-02 |
2015-07-08 |
范国煌 |
调节巨噬细胞极化并抗糖尿病的五环化合物及其应用
|
|
GB201317363D0
(en)
|
2013-10-01 |
2013-11-13 |
Eisai Ltd |
Novel compounds
|
|
CA2930085C
(en)
|
2013-12-09 |
2021-11-02 |
Unilever Plc |
Process of making adamantanamides
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
JP6602779B2
(ja)
|
2014-02-13 |
2019-11-06 |
インサイト・コーポレイション |
Ｌｓｄ１阻害剤としてのシクロプロピルアミン類
|
|
EP3105218B1
(en)
|
2014-02-13 |
2019-09-25 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
EP3105219B9
(en)
|
2014-02-13 |
2018-10-03 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
CN106458934B
(zh)
|
2014-04-18 |
2019-08-16 |
米伦纽姆医药公司 |
喹喔啉化合物及其用途
|
|
SG11201608943VA
(en)
|
2014-04-30 |
2016-11-29 |
Univ Columbia |
Substituted 4-phenylpiperidines, their preparaiton and use
|
|
JP2017516850A
(ja)
|
2014-05-23 |
2017-06-22 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｊａｋ阻害剤である５−クロロ−２−ジフルオロメトキシフェニルピラゾロピリミジン化合物
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
US9695167B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
CA2974078A1
(en)
|
2015-01-20 |
2016-07-28 |
Millennium Pharmaceuticals, Inc. |
Quinazoline and quinoline compounds and uses thereof
|
|
EP3273779A4
(en)
|
2015-03-25 |
2018-09-05 |
Vanderbilt University |
Binary compositions as disruptors of orco-mediated odorant sensing
|
|
EP3277689B1
(en)
|
2015-04-03 |
2019-09-04 |
Incyte Corporation |
Heterocyclic compounds as lsd1 inhibitors
|
|
MY189367A
(en)
|
2015-08-12 |
2022-02-08 |
Incyte Corp |
Salts of an lsd1 inhibitor
|
|
CA3010615C
(en)
|
2016-01-14 |
2024-02-20 |
Beth Israel Deaconess Medical Center, Inc. |
Mast-cell modulators and uses thereof
|
|
EP3210469A1
(de)
*
|
2016-02-23 |
2017-08-30 |
Bayer Cropscience AG |
Verwendung von substituierten thio-1,2,4-triazolen zur steigerung der stresstoleranz in pflanzen
|
|
TWI833686B
(zh)
|
2016-04-22 |
2024-03-01 |
美商英塞特公司 |
Lsd1 抑制劑之調配物
|
|
WO2018187810A1
(en)
|
2017-04-07 |
2018-10-11 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
|
|
MX387969B
(es)
|
2017-05-22 |
2025-03-19 |
Hoffmann La Roche |
Composiciones y compuestos terapéuticos, y métodos para su uso.
|
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
|
US11174263B2
(en)
|
2018-12-31 |
2021-11-16 |
Biomea Fusion, Inc. |
Inhibitors of menin-MLL interaction
|
|
SG11202106304RA
(en)
|
2018-12-31 |
2021-07-29 |
Biomea Fusion Llc |
Irreversible inhibitors of menin-mll interaction
|
|
TWI834795B
(zh)
|
2019-01-08 |
2024-03-11 |
日商杏林製藥股份有限公司 |
15-pgdh抑制劑
|
|
EP3917911A1
(en)
*
|
2019-01-31 |
2021-12-08 |
Kyorin Pharmaceutical Co., Ltd. |
15-pgdh inhibitors
|
|
CN109966298A
(zh)
*
|
2019-05-10 |
2019-07-05 |
辽宁大学 |
托伐普坦在制备降血脂药物中的应用
|
|
EP4208438A4
(en)
*
|
2020-08-28 |
2025-01-22 |
The Regents of the University of California |
COMPOSITIONS AND METHODS FOR TREATING AMYLOID-RELATED DISEASES
|
|
AU2021363703A1
(en)
*
|
2020-10-23 |
2023-06-22 |
S2Cbio Inc. |
Cftr modulator compounds, compositions, and uses thereof
|
|
TW202320796A
(zh)
|
2021-08-11 |
2023-06-01 |
美商拜歐米富士恩股份有限公司 |
用於糖尿病的menin-mll相互作用之共價抑制劑
|
|
US12018032B2
(en)
|
2021-08-20 |
2024-06-25 |
Biomea Fusion, Inc. |
Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction
|
|
WO2024155710A1
(en)
|
2023-01-18 |
2024-07-25 |
Biomea Fusion, Inc. |
Crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6- yl]phenyl]-4-[[3(r)-[(l-oxo-2-propen-l-yl)amino]-l-piperidinyl]methyl]-2-pyridinecarboxamide as a covalent inhibitor of menin-mll interaction
|
|
WO2025146216A1
(zh)
*
|
2024-01-05 |
2025-07-10 |
成都赜灵生物医药科技有限公司 |
六并五氮杂环酰胺类化合物及其用途
|